Literature DB >> 30208343

Rationale and design of technology assisted stepped collaborative care intervention to improve patient-centered outcomes in hemodialysis patients (TĀCcare trial).

Maria-Eleni Roumelioti1, Jennifer L Steel2, Jonathan Yabes3, Kevin E Vowles4, Yoram Vodovotz5, Scott Beach6, Bruce Rollman7, Steven D Weisbord8, Mark L Unruh1, Manisha Jhamb9.   

Abstract

Most hemodialysis (HD) patients experience symptoms of depression, pain and fatigue that impair their health-related quality of life (HRQOL) significantly. These symptoms are associated with increased hospitalization and mortality, mediated by behavioral factors (e.g. non-adherence to medication and dialysis) and biological factors (e.g. inflammatory cytokines). Prior interventions to alleviate symptoms and improve HRQOL showed limited effectiveness in HD patients and their effect on bio-behavioral mediators is lacking evidence. It is imperative to improve patient-centered dialysis care and to address call from Kidney Disease Improving Global Outcomes (KDIGO) guidelines for integration of symptom assessment and management in routine HD-care. Technology-Assisted stepped Collaborative Care (TĀCcare) is a multi-center randomized controlled trial (RCT) of 150 diverse HD patients from Pennsylvania and New Mexico, designed to compare the effectiveness of a 12-week stepped collaborative care intervention (cognitive behavioral therapy, CBT) with an attention control arm of technology-delivered health education. Collaborative care provides an integrated multi-disciplinary structured management plan. Furthermore, a stepped approach to pharmacotherapy and/or CBT allows for individualization of treatment according to patients' clinical status, preferences and treatment response. To simplify the delivery of CBT and to minimize patient and provider burden, we will use live video-conferencing with patients in dialysis units. We will examine the effect of these interventions on patient symptoms, HRQOL, treatment adherence and inflammatory biomarkers. This RCT tests a readily implementable intervention that can be integrated in routine HD-care and will generate novel and meaningful insights on strategies to alleviate common symptoms and improve HRQOL in HD.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Depression; Fatigue; Hemodialysis patients; Pain; Patient-centered Outcomes; Symptoms

Mesh:

Year:  2018        PMID: 30208343      PMCID: PMC6168366          DOI: 10.1016/j.cct.2018.09.002

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  106 in total

1.  Covariate adjustments in randomized controlled trials increased study power and reduced biasedness of effect size estimation.

Authors:  Paul H Lee
Journal:  J Clin Epidemiol       Date:  2016-02-24       Impact factor: 6.437

2.  Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems.

Authors:  Stuart J Pocock; Susan E Assmann; Laura E Enos; Linda E Kasten
Journal:  Stat Med       Date:  2002-10-15       Impact factor: 2.373

3.  Short- and long-term efficacy of brief cognitive-behavioral therapy for patients with chronic temporomandibular disorder pain: a randomized, controlled trial.

Authors:  Judith A Turner; Lloyd Mancl; Leslie A Aaron
Journal:  Pain       Date:  2006-02-21       Impact factor: 6.961

4.  Ecological momentary assessment: what it is and why it is a method of the future in clinical psychopharmacology.

Authors:  Debbie S Moskowitz; Simon N Young
Journal:  J Psychiatry Neurosci       Date:  2006-01       Impact factor: 6.186

5.  Symptom burden, depression, and quality of life in chronic and end-stage kidney disease.

Authors:  Khaled Abdel-Kader; Mark L Unruh; Steven D Weisbord
Journal:  Clin J Am Soc Nephrol       Date:  2009-05-07       Impact factor: 8.237

6.  Methylphenidate and/or a nursing telephone intervention for fatigue in patients with advanced cancer: a randomized, placebo-controlled, phase II trial.

Authors:  Eduardo Bruera; Sriram Yennurajalingam; J Lynn Palmer; Pedro E Perez-Cruz; Susan Frisbee-Hume; Julio A Allo; Janet L Williams; Marlene Z Cohen
Journal:  J Clin Oncol       Date:  2013-05-20       Impact factor: 44.544

Review 7.  Behavioral symptoms in patients with breast cancer and survivors.

Authors:  Julienne E Bower
Journal:  J Clin Oncol       Date:  2008-02-10       Impact factor: 44.544

8.  The prevalence and treatment of depression among patients starting dialysis.

Authors:  Suzanne Watnick; Paul Kirwin; Rex Mahnensmith; John Concato
Journal:  Am J Kidney Dis       Date:  2003-01       Impact factor: 8.860

9.  Ecological momentary assessment of fatigue, sleepiness, and exhaustion in ESKD.

Authors:  Khaled Abdel-Kader; Manisha Jhamb; Lee Anne Mandich; Jonathan Yabes; Robert M Keene; Scott Beach; Daniel J Buysse; Mark L Unruh
Journal:  BMC Nephrol       Date:  2014-02-06       Impact factor: 2.388

Review 10.  Nonadherence to Medication Therapy in Haemodialysis Patients: A Systematic Review.

Authors:  Saurav Ghimire; Ronald L Castelino; Nicole M Lioufas; Gregory M Peterson; Syed Tabish R Zaidi
Journal:  PLoS One       Date:  2015-12-04       Impact factor: 3.240

View more
  4 in total

1.  A Step in the Right Direction: The Promise of PROMs in Routine Hemodialysis Care.

Authors:  Jane Ogden Schell; Dale Ellen Lupu
Journal:  Clin J Am Soc Nephrol       Date:  2020-08-25       Impact factor: 8.237

2.  Psychosocial Impact of COVID-19 Pandemic on Patients with End-Stage Kidney Disease on Hemodialysis.

Authors:  Jacqueline Lee; Jennifer Steel; Maria-Eleni Roumelioti; Sarah Erickson; Larissa Myaskovsky; Jonathan G Yabes; Bruce L Rollman; Steven Weisbord; Mark Unruh; Manisha Jhamb
Journal:  Kidney360       Date:  2020-10-20

Review 3.  Nonpharmacologic Treatments for Opioid Reduction in Patients With Advanced Chronic Kidney Disease.

Authors:  Carrie E Brintz; Martin D Cheatle; Laura M Dember; Alicia A Heapy; Manisha Jhamb; Amanda J Shallcross; Jennifer L Steel; Paul L Kimmel; Daniel Cukor
Journal:  Semin Nephrol       Date:  2021-01       Impact factor: 4.472

4.  Pain management in patients with chronic kidney disease and end-stage kidney disease.

Authors:  Payel J Roy; Melanie Weltman; Laura M Dember; Jane Liebschutz; Manisha Jhamb
Journal:  Curr Opin Nephrol Hypertens       Date:  2020-11       Impact factor: 3.416

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.